Literature DB >> 24044974

Multifunctional aspects of allopregnanolone in stress and related disorders.

Anjana Bali1, Amteshwar Singh Jaggi.   

Abstract

Allopregnanolone (3α-hydroxy-5α-pregnan-20-one) is a major cholesterol-derived neurosteroid in the central nervous system and is synthesized from progesterone by steroidogenic enzymes, 5α-reductase (the rate-limiting enzyme) and 3α-hydroxysteroid dehydrogenase. The pathophysiological role of allopregnanolone in neuropsychiatric disorders has been highlighted in several investigations. The changes in neuroactive steroid levels are detected in stress and stress-related disorders including anxiety, panic and depression. The changes in allopregnanolone in response to acute stressor tend to restore the homeostasis by dampening the hyper-activated HPA axis. However, long standing stressors leading to development of neuropsychiatric disorders including depression and anxiety are associated with decrease in the allopregnanolone levels. GABAA receptor complex has been considered as the primary target of allopregnanolone and majority of its inhibitory actions are mediated through GABA potentiation or direct activation of GABA currents. The role of progesterone receptors in producing the late actions of allopregnanolone particularly in lordosis facilitation has also been described. Moreover, recent studies have also described the involvement of other multiple targets including brain-derived neurotrophic factor (BDNF), glutamate, dopamine, opioids, oxytocin, and calcium channels. The present review discusses the various aspects of allopregnanolone in stress and stress-related disorders including anxiety, depression and panic.
© 2013.

Entities:  

Keywords:  3α-HSD; 3α-hydroxysteroid dehydrogenase; AlloP; Allopregnanolone; Anxiety; BDNF; Brain-derived neurotrophic factor; CRF; Corticotropin releasing factor; Depression; GABA; HPA; HVA; Homovanillic acid; Hypothalamus-pituitary- adrenal axis; MAPK; Msitogen-activated protein kinases; N-methyl-D-aspartate; NKCC1; NMDA; NTS; Na(+)-K(+)-Cl(-) co-transporter; Nucleus tractus solitaries; PBR; PKA; PVN; Panic; Paraventricular nucleus; Peripheral benzodiazepine receptors; Protein kinase A; SBBS; SON; Spontaneous excitatory postsynaptic current; Steroidogenic stimulant; Stress; Supraoptic nucleus; TSPO; TSST; Translocator protein; Trier Social Stress test; VMH; Ventromedial hypothalamus; mPFC; median prefrontal cortex; sEPSCs

Mesh:

Substances:

Year:  2013        PMID: 24044974     DOI: 10.1016/j.pnpbp.2013.09.005

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  23 in total

1.  Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone Levels.

Authors:  Lauren Osborne; Makena Clive; Mary Kimmel; Fiona Gispen; Jerry Guintivano; Tori Brown; Olivia Cox; Jennifer Judy; Samantha Meilman; Aviva Braier; Matthias W Beckmann; Johannes Kornhuber; Peter A Fasching; Fernando Goes; Jennifer L Payne; Elisabeth B Binder; Zachary Kaminsky
Journal:  Neuropsychopharmacology       Date:  2015-10-27       Impact factor: 7.853

Review 2.  Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Authors:  Abdulmaged M Traish; Roberto Cosimo Melcangi; Marco Bortolato; Luis M Garcia-Segura; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

3.  Oxytocin receptor DNA methylation in postpartum depression.

Authors:  Mary Kimmel; Makena Clive; Fiona Gispen; Jerry Guintivano; Tori Brown; Olivia Cox; Matthias W Beckmann; Johannes Kornhuber; Peter A Fasching; Lauren M Osborne; Elisabeth Binder; Jennifer L Payne; Zachary Kaminsky
Journal:  Psychoneuroendocrinology       Date:  2016-04-08       Impact factor: 4.905

4.  Investigating the stress attenuating potential of furosemide in immobilization and electric foot-shock stress models in mice.

Authors:  Aalamjeet Kaur; Anjana Bali; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-01-21       Impact factor: 3.000

5.  5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients.

Authors:  Roberto Carlos Agis-Balboa; Alessandro Guidotti; Graziano Pinna
Journal:  Psychopharmacology (Berl)       Date:  2014-04-30       Impact factor: 4.530

6.  Lower allopregnanolone during pregnancy predicts postpartum depression: An exploratory study.

Authors:  Lauren M Osborne; Fiona Gispen; Abanti Sanyal; Gayane Yenokyan; Samantha Meilman; Jennifer L Payne
Journal:  Psychoneuroendocrinology       Date:  2017-02-16       Impact factor: 4.905

7.  Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind study.

Authors:  Ariadna Forray; Kathryn Gilstad-Hayden; Cristine Suppies; Debra Bogen; Mehmet Sofuoglu; Kimberly A Yonkers
Journal:  Psychoneuroendocrinology       Date:  2017-09-14       Impact factor: 4.905

Review 8.  Loneliness: clinical import and interventions.

Authors:  Stephanie Cacioppo; Angela J Grippo; Sarah London; Luc Goossens; John T Cacioppo
Journal:  Perspect Psychol Sci       Date:  2015-03

9.  Progesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS.

Authors:  Jason J Paris; Jason Fenwick; Jay P McLaughlin
Journal:  Horm Behav       Date:  2014-04-12       Impact factor: 3.587

10.  Prenatal Exposure to Bisphenols and Phthalates and Postpartum Depression: The Role of Neurosteroid Hormone Disruption.

Authors:  Melanie H Jacobson; Cheryl R Stein; Mengling Liu; Marra G Ackerman; Jennifer K Blakemore; Sara E Long; Graziano Pinna; Raquel Romay-Tallon; Kurunthachalam Kannan; Hongkai Zhu; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.